Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...

Cigna's pharmacy benefits company, Evernorth, reached pricing deals with Eli Lilly and Novo Nordisk to reduce expenses and ...

Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss medications WEGOVY® and ZEPBOUND® more available to ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Cigna is reducing monthly out-of-pocket costs to $200 for patients using weight-loss drugs Wegovy and Zepbound. These ...

The popularity of GLP-1 drugs has insurance companies scrambling to satisfy consumer access while reining in exorbitant costs ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers manage GLP-1 utilization. Cigna also posted first quarter results well above ...

The Cigna Group reported a strong start to the year, with first-quarter 2025 revenues rising 14% to $65.5 billion.

Cigna's first-quarter financial results got a big lift from Evernorth Health Services’ strong performance. Cigna has made substantial investments over the past year in the segment, which houses ...

The Cigna Group CI reported first-quarter 2025 adjusted earnings per share (EPS) of $6.74, which outpaced the Zacks Consensus Estimate by 5.5%. Also, the bottom line increased 4.2% year over year.